OTCMKTS:AYTU
Aytu Bioscience Stock News
$2.89
+0.0831 (+2.96%)
At Close: May 01, 2024
Milestone Pharmaceuticals (MIST) Looks Good: Stock Adds 6.5% in Session
12:37pm, Wednesday, 10'th Jun 2020
Milestone Pharmaceuticals (MIST) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Monopar Therapeutics (MNPR) Catches Eye: Stock Jumps 11.2%
02:00pm, Tuesday, 09'th Jun 2020
Monopar Therapeutics (MNPR) saw a big move last session, as its shares jumped more than 11% on the day, amid huge volumes.
IDEAYA (IDYA) Looks Good: Stock Adds 10.2% in Session
12:58pm, Tuesday, 09'th Jun 2020
IDEAYA (IDYA) saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes.
Aytu BioScience Announces Results from a National Cancer Institute Evaluation of the Company’s Licensed COVID-19 IgG/IgM Rapid Test
12:00pm, Tuesday, 09'th Jun 2020
National Cancer Institute's (NCI) analysis of COVID-19 IgG/IgM Rapid Test Cassette Reported 100% Combined Sensitivity, and 97.5% Combined Specificity for the Lateral Flow Immunoassay ENGLEWOOD, CO / A
Aytu BioScience Set to Join Russell 3000(R) Index
12:00pm, Monday, 08'th Jun 2020
ENGLEWOOD, CO / ACCESSWIRE / June 8, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company (the "Company") focused on commercializing novel products that address significant .
Is Aytu BioScience, Inc. (AYTU) A Good Stock To Buy?
07:13pm, Friday, 05'th Jun 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Aytu BioScience Announces Significant Improvement in Natesto(R) Patient Access in the United States
12:00pm, Wednesday, 03'rd Jun 2020
ENGLEWOOD, CO / ACCESSWIRE / June 3, 2020 / Aytu BioScience, Inc. (AYTU) (the "Company"), a specialty pharmaceutical company focused on commercializing novel products that address significant patient
Has Aytu Bioscience (AYTU) Outpaced Other Medical Stocks This Year?
03:30pm, Tuesday, 02'nd Jun 2020
Is (AYTU) Outperforming Other Medical Stocks This Year?
Russia Says It's Developing UV Light Therapy to Treat Coronavirus
10:59am, Tuesday, 02'nd Jun 2020
Scientists warned about the dangers of UV radiation after U.S. President Trump suggested it as treatment.
Aytu BioScience Announces $15 Million Debt Retirement
08:01pm, Monday, 01'st Jun 2020
Company Retires $15M Obligation Assumed with Previously Announced Cerecor Commercial Portfolio Asset Purchase Company's Debt Reduced to Approximately $1 Million ENGLEWOOD, CO / ACCESSWIRE / June 1, 20
Aytu BioScience Announces Emergency Use Authorization of COVID-19 IgG/IgM Rapid Test
12:00pm, Monday, 01'st Jun 2020
Fourth FDA Emergency Use Authorization of a COVID-19 IgG/IgM Lateral Flow Rapid Test 1.4 Million Rapid Tests Available for Distribution at Company's Warehouse ENGLEWOOD, CO / ACCESSWIRE / June 1, 2020
Coronavirus Impact on Healthcare Acquired Infection Market
04:45pm, Tuesday, 26'th May 2020
May 26, 2020 (Heraldkeepers) --
New York, May 26, 2020: You will get latest updated report as per the COVID-19 Impact on this industry. Our updated reports...
Aytu BioScience, Inc. (NASDAQ:AYTU): Is Breakeven Near?
12:40pm, Saturday, 16'th May 2020
Aytu BioScience, Inc.'s (NASDAQ:AYTU): Aytu BioScience, Inc., a specialty pharmaceutical company, focuses on developing...
Aytu BioScience, Inc.'s (AYTU) CEO Joshua Disbrow on Q3 2020 Results - Earnings Call Transcript
12:34am, Friday, 15'th May 2020
Aytu BioScience, Inc. (NASDAQ:AYTU) Q3 2020 Results Earnings Conference Call May 14, 2020, 04:30 PM ET Company Participants Joshua Disbrow - Chairman & CEO
Aytu Bioscience, Inc. (AYTU) Reports Q3 Loss, Tops Revenue Estimates
11:15pm, Thursday, 14'th May 2020
Aytu Bioscience, Inc. (AYTU) delivered earnings and revenue surprises of 61.54% and 16.51%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
